Markets
CAH

Sector Update: Healthcare

A generic image of two people across each other
Credit: Shutterstock photo

Healthcare stocks are mostly lower with the NYSE Healthcare Sector Index declining about 0.3% and shares of healthcare companies in the S&P 500 also falling about 0.3% as a group.

In company news, CVS Caremark and Cardinal Health ( CAH ) are each higher today with the companies announcing the creation of the largest generic sourcing entity in the country.

Under terms of the deal, CVS will receive $25 million in quarterly payments from CAH, with the firms contributing their sourcing and supply chain expertise to the 50/50 joint venture and also committing to source generic drugs through it.

The companies today also announced a three-year extension through June 2019 of CAH's existing pharmaceutical distribution agreements with CVS.

CAH shares last traded up 3.5% higher at $66.51 while CVS was up 1.9% to $68.02 a share.

In other sector news,

(+) NURO, Signs Omron Healthcare China to be its exclusive distributor of NC-stat DPNCheck, the company's point-of-care test, for diabetes in China.

(-) DGX, Bank of America cuts its rating for the diagnostics-testing company to Underperform from buy while also reducing its price target for the stock by $9 to $55 a share.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CAH

Other Topics

Commodities

Latest Markets Videos